Fulfilling the promise of targeted therapeutics in oncology via companion diagnostics : a perspective on pipeline trends and co-development strategies
Thesis (S.M.)--Harvard-MIT Division of Health Sciences and Technology, 2011.
Main Author: | Mehrotra, Anand |
---|---|
Other Authors: | Richard J. Cohen, Keith Flaherty and Mara Aspinall. |
Format: | Thesis |
Language: | eng |
Published: |
Massachusetts Institute of Technology
2012
|
Subjects: | |
Online Access: | http://hdl.handle.net/1721.1/68173 |
Similar Items
-
The economic and ethical considerations and implications of the stratification of future oncology therapeutics
by: Sabir, Sameer A
Published: (2010) -
Trends in U.S. regulatory approvals of the biopharmaceutical therapeutic entities
by: Graham, James B., 1976-
Published: (2006) -
Opportunities and challenges in oncology targeted drug development : an assessment of the use of prevalence and companion diagnostic performance thresholds to guide clinical trial strategies
by: Vital, Heather Stacey Tomkinson
Published: (2013) -
Regression analysis of oncology drug licensing deal values
by: Hawkins, Paul Allen
Published: (2007) -
Assessing the impact of tumor evolution on oncology drug development and commercialization
by: Sterk, Joseph P. (Sterk, Joseph Phillip)
Published: (2011)